Raymond Damadian
Damadian is the company's largest shareholder, with 8% of stock worth $6.5 million. Despite owning only 8% of the stock, he maintains almost 100% control of the company through a separate class of shares (Class C) that only Damadian controls 2007. Damadian later collaborated with Wilson Greatbatch, one early developer of the implantable pacemaker, to develop an MRI-compatible pacemaker. He invented a stand-up MRI system and has 15 MRI scanning centers across the United States. There are a number of independent MRI centers that use this technology both in the U.S. and around the world. The company conceived and built the world's first Upright Multi-Positional MRI, which was recognized as The Invention of the Year in 2007 by the Intellectual Properties Owners Association Education Foundation.
Cheon Jinwoo
Through his fundamental studies, he integrated the fields of inorganic nanomaterials and medical science. This nexus led to the advent of a new field known as "nanomedicine". In 2005, for the first time, he demonstrated the principle of size-dependent MRI contrast effects using nanoparticles. This enabled the development of a new class of nano-MRI contrast agent, MEIO (magnetism-engineered iron oxide) which displayed 10 times stronger MRI signals compared to those of conventional contrast agents. This study opened possibilities to the advancement of the early stage diagnosis of cancer and stands as a research milestone in the field. In addition, Cheon developed multimodal probes to enhance the imaging accuracy by designing opto-magnetic probe, PET-MRI probes, dual-mode T1-T2 MRI probes. Successful discrimination of true signal of biological targets could be attained by these developments, opening a new avenue to have accurate diagnosis of disease.